Researchers have reported that statins could have an antimicrobial effect against Staphylococcus aureus – indicating that statin users may have a decreased risk of S. aureus bloodstream infections outside of hospitals.
Browsing: Disease Area > Bacterial
In this editorial the authors discuss the current methods for identifying carbapenemase producers and give a future perspective, highlighting the imemdiate action required to tackle the broader problem of antimicrobial resistance.
Julie Kaiser discusses the findings and implications of a recent study published in PNAS modeling the sequence of events that increases the risk of colonization and infection with multidrug-resistant (MDR) bacteria.
While sepsis is well defined clinically, the molecular immunological mechanisms that underlie the development of sepsis are poorly understood.
Researchers have discovered that a leaderless intercellular peptide signal may contribute to group A Streptococcus virulence; providing a framework for the identification in other microorganisms that may potentially serve as therapeutic targets.
In this review, the authors consider phage therapy that can be used for treating bacterial infections in humans, domestic animals and even biocontrol in foods. They also explore common practice – both experimental and, in certain regions of the world, clinical – of mixing therapeutic phages into cocktails consisting of multiple virus types.
New research displays how intestinal microbiota could regulate body composition; providing an insight into the molecular link between gut microbiota and the circadian clock via transcription factor NFIL3.
Researchers have pinpointed the four key pathogens responsible for diarrheal disease, a number one cause of morbidity among young children in sub-Saharan Africa and South Asia, highlighting the possible interventions available.
More than a century after its description and the discovery of the bacterial etiological agent, and despite its major burden globally, leptospirosis remains largely under-recognized.